Literature DB >> 33273317

Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.

Joseph P Grande1, Erika S Helgeson2, Arthur J Matas3.   

Abstract

BACKGROUND: Glomerular size in renal allografts is impacted by donor-recipient factors and response to injury. In serial biopsies of patients with well-functioning grafts, increased glomerular size correlates with better survival. However, no previous study has addressed the association of glomerular size at the time of a for-cause biopsy and clinical/histopathologic markers of injury, or effect on long-term graft outcome.
METHODS: Two cohorts of kidney transplant recipients enrolled in the Deterioration of Kidney Allograft Function study were evaluated. The prospective cohort (PC, n = 581): patients undergoing first for-cause kidney biopsy 1.7 ± 1.4 (mean ± SD) y posttransplant; and the cross-sectional cohort (CSC, n = 446): patients developing new-onset renal function deterioration 7.7 ± 5.6 y posttransplant. Glomerular planar surface area and diameter were measured on all glomeruli containing a vascular pole. Kidney biopsy was read centrally in a blinded fashion according to the Banff criteria.
RESULTS: Glomerular area was significantly higher in the CSC than the PC; time from transplant to indication biopsy was associated with glomerular area in both cohorts (P values ≤ 0.001). Glomerular area was associated with indices of microvascular inflammation (glomerulitis, peritubular capillary infiltrates; P values ≤ 0.001) and segmental glomerulosclerosis (P value < 0.0001). In the CSC, higher glomerular area was associated with higher estimated glomerular filtration rate (P value ≤ 0.001) and increased graft survival after accounting for microvascular inflammation (adjusted hazard ratio = 0.967; 95% confidence interval: 0.948-0.986; hazard ratio in biopsies without evidence of diabetes or antibody mediated rejection = 0.919, 95% confidence interval: 0.856-0.987).
CONCLUSIONS: Glomerular size is associated with histopathologic features present at the time of indication biopsy and with increased graft survival in the CSC.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33273317      PMCID: PMC8166916          DOI: 10.1097/TP.0000000000003570

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


  33 in total

1.  Banff 07 classification of renal allograft pathology: updates and future directions.

Authors:  K Solez; R B Colvin; L C Racusen; M Haas; B Sis; M Mengel; P F Halloran; W Baldwin; G Banfi; A B Collins; F Cosio; D S R David; C Drachenberg; G Einecke; A B Fogo; I W Gibson; D Glotz; S S Iskandar; E Kraus; E Lerut; R B Mannon; M Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; I Roberts; D Seron; R N Smith; M Valente
Journal:  Am J Transplant       Date:  2008-02-19       Impact factor: 8.086

2.  Does allograft size really matter in the long-term outcome of living donor kidney transplantation?

Authors:  H Akoglu; T Yildirim; G Eldem; R Yilmaz; T Hazirolan; F T Aki; M Arici; Y Erdem
Journal:  Transplant Proc       Date:  2015-03       Impact factor: 1.066

3.  Estimation of total glomerular number in stable renal transplants.

Authors:  Xavier Fulladosa; Francesc Moreso; Jose A Narváez; Josep M Grinyó; Daniel Serón
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

4.  Baseline glomerular size as a predictor of function in human renal transplantation.

Authors:  R Abdi; D Slakey; D Kittur; J Burdick; L Racusen
Journal:  Transplantation       Date:  1998-08-15       Impact factor: 4.939

5.  Inflammation in areas of fibrosis: The DeKAF prospective cohort.

Authors:  Arthur J Matas; Erika S Helgeson; Robert Gaston; Fernando Cosio; Roslyn Mannon; Bertram L Kasiske; Lawrence Hunsicker; Sita Gourishankar; David Rush; J Michael Cecka; John Connett; Joseph P Grande
Journal:  Am J Transplant       Date:  2020-04-15       Impact factor: 8.086

6.  Effect of donor/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation.

Authors:  Amgad E el-Agroudy; Nabil A Hassan; Mohamed A Bakr; Mohamed A Foda; Ahmed A Shokeir; Ahmed B Shehab el-Dein
Journal:  Am J Nephrol       Date:  2003-08-06       Impact factor: 3.754

7.  The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Authors:  A Loupy; M Haas; K Solez; L Racusen; D Glotz; D Seron; B J Nankivell; R B Colvin; M Afrouzian; E Akalin; N Alachkar; S Bagnasco; J U Becker; L Cornell; C Drachenberg; D Dragun; H de Kort; I W Gibson; E S Kraus; C Lefaucheur; C Legendre; H Liapis; T Muthukumar; V Nickeleit; B Orandi; W Park; M Rabant; P Randhawa; E F Reed; C Roufosse; S V Seshan; B Sis; H K Singh; C Schinstock; A Tambur; A Zeevi; M Mengel
Journal:  Am J Transplant       Date:  2017-01       Impact factor: 8.086

8.  Impact of adjusted kidney volume measured in the bench surgery on one-year renal function in kidney transplantation.

Authors:  Flávio Vasconcelos Ordones; Pedro Ivo Rocchetti Pajolli; Rodrigo Guerra da Silva; Hamilto Akihissa Yamamoto; Fernando Fereira Gomes Filho; Paulo Roberto Kawano; João Luiz Amaro; Luis Gustavo Modelli de Andrade
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

9.  Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R2 Values in Relation to Renal Outcomes.

Authors:  Hiroshi Kataoka; Takahito Moriyama; Shun Manabe; Keiko Kawachi; Yusuke Ushio; Saki Watanabe; Taro Akihisa; Shiho Makabe; Masayo Sato; Naomi Iwasa; Yukako Sawara; Mamiko Ohara; Sekiko Taneda; Keiko Uchida; Kazuho Honda; Toshio Mochizuki; Ken Tsuchiya; Kosaku Nitta
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

10.  The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Authors:  M Haas; A Loupy; C Lefaucheur; C Roufosse; D Glotz; D Seron; B J Nankivell; P F Halloran; R B Colvin; Enver Akalin; N Alachkar; S Bagnasco; Y Bouatou; J U Becker; L D Cornell; J P Duong van Huyen; I W Gibson; Edward S Kraus; R B Mannon; M Naesens; V Nickeleit; P Nickerson; D L Segev; H K Singh; M Stegall; P Randhawa; L Racusen; K Solez; M Mengel
Journal:  Am J Transplant       Date:  2018-01-21       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.